Skip to content

VITALUMEN PHARM OÜ

Registry code (registrikood) 14508819Private limited company (Osaühing)VAT EE102078189Activity (EMTAK 47731): Ravimite jaemüükActive

Narva linn, Ida-Viru County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€3.3M
▲ 3.7% vs 2024
Profit before tax (2025)
€45k
Employees, FTE (2025)
12
State taxes paid, last 4 quarters
€255k

Revenue, profit and employees, 2019–2025

€820k2019€2.9M2020€3.7M2021€3.4M2022€3.2M2023€3.2M2024€3.3M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€819,782€9,173€9,173€4,0505
2020€2,877,591€16,658€16,658€20,70915
2021€3,721,516-€33,333-€33,332-€12,62316
2022€3,376,021€13,761€13,760€1,13615
2023€3,190,949-€26,986-€26,986-€25,85014
2024€3,171,966€22,698€22,700-€3,15012
2025€3,290,367€45,094€45,096€41,94612

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€59,405€264,677€260,627—€4,050
2020€89,727€695,702€674,993—€20,709
2021€29,937€670,438€683,061—-€12,623
2022€41,810€543,503€542,367—€1,136
2023€34,997€477,434€503,284—-€25,850
2024€29,271€498,093€501,243—-€3,150
2025€29,020€543,404€501,458—€41,946

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€60,609€46,827€992,54721
2022 Q2€67,623€48,054€999,14420
2022 Q3€62,524€46,131€831,64018
2022 Q4€59,776€42,399€887,83718
2023 Q1€55,592€41,520€826,30518
2023 Q2€51,433€43,327€831,79220
2023 Q3€57,636€46,779€851,43219
2023 Q4€61,016€46,329€907,01118
2024 Q1€68,484€49,088€861,39318
2024 Q2€61,525€47,095€836,30816
2024 Q3€60,480€45,237€808,15217
2024 Q4€61,231€46,622€875,34418
2025 Q1€67,603€50,539€822,44718
2025 Q2€65,027€49,596€841,32219
2025 Q3€68,059€51,299€859,53617
2025 Q4€68,267€48,566€972,84518
2026 Q1€62,864€46,418€930,03118
2026 Q2€57,989€45,525€932,94617
2026 Q3€65,845€51,133€968,31315

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), VITALUMEN PHARM OÜ reported revenue of €3,290,367.

The company closed the 2025 financial year with a net profit of €45,096.

Revenue increased by 3.7% from €3,171,966 in 2024 to €3,290,367 in 2025.

Revenue grew at a compound annual rate of 26.1% between 2019 and 2025.

Equity accounted for 7.7% of total assets of €543,404 at the end of the 2025 reporting period.

With 12 full-time-equivalent employees in 2025, revenue per employee was €274,197.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, VITALUMEN PHARM OÜ reported €3,804,135 in turnover.

EMTA recorded 15 employees for the quarter ending Q3 2026, compared with 12 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.